Medicine
Therapeutic Hypothermia in Post-Cardiac Arrest Care
Quick fact
For every 1 °C reduction in body temperature, brain metabolism drops by approximately 6–7%. This is why cooling can slow the cascade of brain injury after cardiac arrest.
Why this is interesting
Imagine a person whose heart has just been restarted after cardiac arrest. But the fight for their life isn't over—the brain faces a hidden threat, and a surprising treatment involves cooling the body. Why would doctors intentionally make a patient cold?
Read the full explanation
Understanding Therapeutic Hypothermia in Post-Cardiac Arrest Care
When the heart stops, the brain and other vital organs receive no oxygen. After the heart is restarted (as in CPR), a second wave of damage occurs—reperfusion injury. This is triggered by a burst of harmful chemicals and an inflammatory response as blood flow resumes. Therapeutic hypothermia is a treatment that cools the patient's body to a target temperature, typically 32–36°C (89.6–96.8°F) for 24 hours, to slow down the brain's metabolism. This gives the brain a kind of 'breather' by reducing the workload on cells, reducing energy demand, and dampening the inflammatory cascade. The result is less damage to brain cells, leading to a greater chance of surviving without severe neurological disability. Although it seems counterintuitive to cool a critically ill patient, the protective effects significantly improve outcomes.
A deeper explanation
The mechanism behind therapeutic hypothermia is multifactorial. Cooling reduces the cerebral metabolic rate of oxygen consumption (CMRO₂), which directly lessens the need for ATP, thereby protecting against energy failure during vulnerable periods. Additionally, it inhibits the excitotoxic release of glutamate, reduces free radical generation, and suppresses apoptosis (programmed cell death). Hypothermia also stabilizes cell membranes and reduces the inflammatory response that exacerbates reperfusion injury. In clinical practice, targeted temperature management has become standard after cardiac arrest when the patient remains unconscious after return of spontaneous circulation (ROSC). Induction is achieved via rapid infusion of cold saline or surface cooling pads, followed by strict temperature management to avoid fever, which is harmful to the recovering brain. Despite decades of research, precise optimal temperature and duration are still debated, but the core principle remains: cooling protects the brain. This therapy is now a pillar of post-cardiac arrest care, demonstrating a profound link between cellular biology and emergency medicine.